arrow
A

Abdullah Husain

department of pathology
H指数:6
被引数:200

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Repurposing Resmetirom suppresses MASH-associated hepatocellular carcinoma, with mechanistic implications of MDK/LRP1-mediated metabolic reprogramming and immunosuppression

曲美替尼的重新利用抑制了MASH相关的肝细胞癌,具有MDK/LRP1介导的代谢重编程和免疫抑制的机制学意义

2026-01-010
PRE
Multimodal sequencing of neoadjuvant nivolumab treatment in hepatocellular carcinoma reveals cellular and molecular immune landscape for drug response

肝细胞癌新辅助纳武利尤单抗治疗的多模态测序揭示了药物反应的细胞和分子免疫景观

2025-04-090
OA